Home › FDA clears expanded use of Pfizer's breast cancer med IBRANCE
 

Keywords :   


FDA clears expanded use of Pfizer's breast cancer med IBRANCE

2016-02-20 09:04:41| Biotech - Topix.net

The FDA approves Pfizer's supplement New Drug Application for IBRANCE . It is now cleared for the treatment of hormone receptor-positive , human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in combination with fulvestrant [AstraZeneca's FASLODEX ] in women with disease progression following endocrine therapy.

Tags: med expanded cancer breast

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »